IRB approval
Emory UniversityThe Georgia CTSA Rapid Response Team expedited high-priority studies of experimental therapeutics and vaccines. Emory's first COVID-19 patient began receiving infusion therapy of Remdesivir within 48 hours as a result of Georgia CTSA's assistance in coordinating the approvals needed. Representatives from Emory research offices worked together in parallel to expedite 27 COVID-19 studies from March
August 27, 2019For many Clinical and Translational Science Award (CTSA) Program hubs, delays in Institutional Review Board (IRB) approval can feel like a translational roadblock on scientists’ path to implementing research that may ultimately improve public health outcomes. However, as an essential part of ensuring the welfare of human research subjects, the IRB is crucial to maintaining the highest ethical